PA
IMGN

Perceptive Advisors’s Immunogen Inc IMGN Stock Holding History

Perceptive Advisors’s Portfolio IMGN Stock Details IMGN Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2017
Q4 		– Sell
-70,126
Closed -$536K – 156
2017
Q3 		$536K Buy
+70,126
New +$466K 0.02% 120
2016
Q3 		– Sell
-25,745
Closed -$79K – 219
2016
Q2 		$79K Buy
+25,745
New +$161K 0.01% 150

Other funds holding IMGN

RG
Redmile Group San Francisco, California $1.51B AUM 164.17% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
ClearBridge Investments
ClearBridge Investments New York $115B AUM 24.78% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
Primecap Management
Primecap Management Pasadena, California $127B AUM 44.11% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Millennium Management
Millennium Management New York $240B AUM 35.51% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Perceptive Advisors's IMGN Position: Q4 2017 in Review

Perceptive Advisors sold out of Immunogen Inc (IMGN) in Q4 2017, closing a stake of 70,126 shares — an estimated $536K sold.

Perceptive Advisors first reported a position in IMGN in Q2 2016 and held it in 2 quarters. The position peaked at $536K in Q3 2017. 200 funds tracked by Wall St. Rank hold IMGN as of Q4 2017.

  • Perceptive Advisors reported no remaining Immunogen Inc position as of Q4 2017 after selling out during the quarter.
  • Perceptive Advisors sold 70,126 Immunogen Inc shares in Q4 2017, an estimated $536K.
  • Perceptive Advisors first reported a position in Immunogen Inc in Q2 2016 and held it in 2 quarters.
  • Perceptive Advisors's Immunogen Inc position peaked at $536K in Q3 2017.
  • 200 funds tracked by Wall St. Rank held Immunogen Inc as of Q4 2017.

Based on Perceptive Advisors's 13F filing for Q4 2017, filed 14 Feb 2018.